Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00181831 · ClinicalTrials.gov registry record
Spectroscopy in Children and Adolescents With Bipolar Disorder
A clinical trial, sponsored by Massachusetts General Hospital.
- Completed
- Registry status
- 80
- Enrollment target
NCT00181831: Completed study, sponsored by Massachusetts General Hospital.
NCT00181831 is a clinical trial that has completed, run by Massachusetts General Hospital. The registered enrollment target is 80 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00181831 has completed, sponsored by Massachusetts General Hospital.
- COMPLETED
- Registry status
- 80 participants
- Enrollment target
Study Summary
The primary aim of this study is to use proton magnetic resonance spectroscopy to look at myo-Inositol containing compounds (Ino) and creatine + phosphocreatine (Cr) in the anterior cingulate of 20 children with bipolar disorder between the ages of 6-17 years old free of risperidone treatment and 20 children with bipolar disorder after an eight-week or longer treatment with risperidone. For comparison, results will also be obtained from 20 controls (without bipolar disorder or ADHD) of the same age and gender as well as from 20 children or adolescents with a diagnosis of Attention Deficit Hyperactivity Disorder. We hypothesize that Ino/Cr levels in the anterior cingulate will correlate positively with manic symptoms using the Young mania rating scale (YMRS). Ino/Cr levels in the anterior cingulate in the anterior cingular gyrus will be lower in subjects who have received eight weeks or longer of risperidone
Interventions
- DEVICE Proton Magnetic Resonance Spectroscopy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 80 participants |
| Start Date | 2002-12 |
| Est. Completion | 2005-11 |
What the finished NCT00181831 record still lists
NCT00181831 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 80 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which Proton Magnetic Resonance Spectroscopy is the first listed.
NCT00181831 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00181831 about?
NCT00181831 is a clinical study titled "Spectroscopy in Children and Adolescents With Bipolar Disorder". The primary aim of this study is to use proton magnetic resonance spectroscopy to look at myo-Inositol containing compounds (Ino) and creatine + phosphocreatine (Cr) in the anterior cingulate of 20 children with bipolar disorder between the ages of 6-17 years old free of risperidone treatment and 20...
What is the current status of trial NCT00181831?
This trial is currently completed. The enrollment target is 80 participants. The study started on 2002-12. Estimated completion is 2005-11.
What interventions are being tested in trial NCT00181831?
The interventions under investigation include: Proton Magnetic Resonance Spectroscopy (DEVICE).
Who is sponsoring clinical trial NCT00181831?
This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01243931 · 80 participants · NA
Optical Coherence Tomography Guided Transepithelial Phototherapeutic Keratectomy
- NCT01659203 · 80 participants · Phase 1
Proton or Photon RT for Retroperitoneal Sarcomas
- NCT01803451 · 80 participants · Early Phase 1
Glucagon-like Peptide 1, Glucose Metabolism and Gastric Bypass
- NCT01964859 · 80 participants · Phase 2
Feasibility Study for Fibroblast Autologous Skin Grafts
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia